Clinical Trial: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07869654) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults' on Oct. 06.

Brief Summary: The goal of this clinical trial is to learn how ATI-105 administered to healthy participants at works in the body at different doses and with or without food. The outcomes of this clinical trial will help to determine if ATI-105 may be able to treat patients with Friedreich's ataxia, a rare and life-threatening nerve-muscle disease that worsens over time. The main questions this study is designed to answer include the following:

* How do single doses or doses for 14 days work in the body?

* Are these doses...